Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Aptose Biosciences Inc. (APTO)
|
Add to portfolio |
|
|
|
| Price: |
$1.49
| | Metrics |
| OS: |
6.52
|
M
| |
|
|
| Market cap: |
$9.71
|
M
| |
|
|
|
Net cash:
|
$23.3
|
M
| |
$3.57
|
per share
|
|
EV:
|
|
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 10.3 | 6.3 |
| Revenue growth | | | | | | -100.0% | 65.0% | |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 10.3 | 6.3 |
| Gross margin | | | | | | | 100.0% | 100.0% |
| Research and development | 28.1 | 46.0 | 29.3 | 16.8 | 18.7 | 6.3 | | |
| General and administrative | 14.5 | 19.5 | 26.5 | 10.0 | 10.4 | 5.6 | 8.3 | 9.8 |
| EBIT | -42.6 | -65.4 | -55.8 | -26.8 | -29.2 | -11.6 | -8.3 | -9.8 |
| EBIT margin | | | | | | | -80.8% | -157.4% |
| Pre-tax income | -41.8 | -65.4 | -55.2 | -26.3 | -28.9 | -11.6 | 0.0 | 0.0 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | | |
| Net income | -41.8 | -65.4 | -55.2 | -26.3 | -28.9 | -11.6 | 0.0 | 0.0 |
| Net margin | | | | | | | 0.0% | 0.0% |
| |
| Diluted EPS | ($0.45) | ($0.73) | ($0.67) | ($0.52) | ($0.86) | ($0.52) | | |
| Shares outstanding (diluted) | 92.9 | 89.1 | 81.8 | 50.2 | 33.4 | 22.3 | | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|